Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene

SIMPLE SUMMARY: Colorectal cancer (CRC) is the third most common cancer in terms of incidence rate in adults and the second most common cause of cancer-related death in Europe. The treatment of metastatic CRC (mCRC) is based on the use of chemotherapy, anti-vascular endothelial growth factor (VEGF),...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Jiménez, Javier, Esteban-Villarrubia, Jorge, Ferreiro-Monteagudo, Reyes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367374/
https://www.ncbi.nlm.nih.gov/pubmed/35954382
http://dx.doi.org/10.3390/cancers14153718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367374/
https://www.ncbi.nlm.nih.gov/pubmed/35954382
http://dx.doi.org/10.3390/cancers14153718

Ejemplares similares